Aligning Interests with Shareholders Through Equity-Compensation Stock Options
First written in FY2017-Q2. 6 of 14 entries say "Achieved", first in FY2017-Q3. Latest entry: FY2022.
6 other companies' latest entry also says "Dropped".
- FY2022DroppedAnnual report
「Regarding non-monetary compensation, the 45th Annual General Meeting of Shareholders held on 22 June 2013 had approved a separate annual limit of ¥100 million for stock compensation-type stock option compensation for directors, excluding outside directors, in addition to basic compensation. The 54th Annual General Meeting of Shareholders held on 23 June 2022 resolved to abolish this limit and introduce the performance-linked share compensation plan, the Stock Benefit Trust (BBT), with an annual limit of 83,700 points per business year for directors, excluding outside directors.」
The previous stock compensation-type stock option compensation limit has been abolished and the company has transitioned to a new performance-linked share compensation plan. - FY2022-Q3AchievedAnnual report
「Fiscal 2021 stock compensation-type share acquisition rights Resolution date 11 November 2021 Categories and number of eligible recipients (people) Company directors, excluding outside directors 4 Executive officers, etc. 8 Number of share acquisition rights (rights)* 526 Class, details and number of shares underlying the share acquisition rights (shares)* Common shares 52,600」
The issue of the fiscal 2021 stock compensation-type share acquisition rights was completed on 10 December 2021, comprising 526 rights covering 52,600 shares. - FY2022-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 11 November 2021, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to set the offering terms and issue share acquisition rights as stock compensation-type stock options for the company's directors, excluding outside directors, and the company's executive officers, including equivalent positions, hereinafter referred to as executive officers, etc.」
The company resolved to issue 526 fiscal 2021 stock compensation-type share acquisition rights to 4 directors and 8 executive officers, etc. The allocation date was set for 10 December 2021 and the exercise period for 13 December 2021 to 12 December 2051. - FY2021-Q3AchievedAnnual report
「Fiscal 2020 stock compensation-type share acquisition rights Resolution date 12 November 2020 Number of share acquisition rights (rights)* 960 Class, details and number of shares underlying the share acquisition rights (shares)* Common shares 96,000」
The issue of the fiscal 2020 stock compensation-type share acquisition rights was completed on 10 December 2020, comprising 960 rights covering 96,000 shares. - FY2021-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 12 November 2020, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to set the offering terms and issue share acquisition rights as stock compensation-type stock options for the company's directors, excluding outside directors, directors of its subsidiaries, and the company's executive officers, including equivalent positions, hereinafter referred to as executive officers, etc.」
The company resolved to issue 960 fiscal 2020 stock compensation-type share acquisition rights to 4 company directors, 2 subsidiary directors and 8 executive officers, etc. - FY2020-Q3AchievedAnnual report
「Fiscal 2019 stock compensation-type share acquisition rights Number of share acquisition rights (rights) 894 Class, details and number of shares underlying the share acquisition rights (shares)* Common shares 89,400」
The issue of the fiscal 2019 stock compensation-type stock options was completed on 11 December 2019, comprising 894 rights covering 89,400 shares. - FY2020-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 12 November 2019, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to set the offering terms and issue share acquisition rights as stock compensation-type stock options for the company's directors, excluding outside directors, directors of its subsidiaries, and the company's executive officers, including equivalent positions, hereinafter referred to as executive officers, etc.」
The company resolved to issue 894 fiscal 2019 stock compensation-type share acquisition rights. The eligible recipients were 4 company directors, 4 subsidiary directors and 4 executive officers, etc.; the allocation date was set for 11 December 2019 and the exercise period for 12 December 2019 to 11 December 2049. - FY2019-Q3AchievedAnnual report
「The share acquisition rights issued during the third-quarter accounting period are as follows. Fiscal 2018 stock compensation-type share acquisition rights Number of share acquisition rights (rights) 772 Class, details and number of shares underlying the share acquisition rights (shares) Common shares 77,200」
The issue of the fiscal 2018 stock compensation-type share acquisition rights resolved in the second quarter of the 51st fiscal year was completed, comprising 772 rights covering 77,200 shares. - FY2019-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 9 November 2018, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to set the offering terms and issue share acquisition rights as stock compensation-type stock options for the company's directors, excluding outside directors, directors of its subsidiaries, and the company's executive officers, including equivalent positions, hereinafter referred to as executive officers, etc.」
The company resolved after the end of the quarter to issue 772 fiscal 2018 stock compensation-type stock options to 6 company directors, 3 subsidiary directors and 3 executive officers, etc. - FY2018-Q3AchievedAnnual report
「The share acquisition rights issued during the third-quarter accounting period are as follows. Fiscal 2017 stock compensation-type share acquisition rights Number of share acquisition rights (rights) 593 Number of shares underlying the share acquisition rights (shares) (Note 1) 59,300」
The issue of the fiscal 2017 stock compensation-type share acquisition rights resolved in the second quarter of the 50th fiscal year was completed during the third-quarter accounting period, comprising 593 rights covering 59,300 shares. - FY2018-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 10 November 2017, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to set the offering terms and issue share acquisition rights as stock compensation-type stock options for the company's directors, excluding outside directors, directors of its subsidiaries, and the company's executive officers, including equivalent positions, hereinafter referred to as executive officers, etc.」
The company resolved to issue 593 new stock compensation-type share acquisition rights. The eligible recipients were 7 company directors, 2 subsidiary directors and 3 executive officers, etc., with the allocation date set for 12 December 2017. - FY2017RestatedAnnual report
「④ Fiscal 2016 stock compensation-type share acquisition rights」
The full-year report also describes the issue of 1,330 fiscal 2016 stock compensation-type share acquisition rights covering 133,000 shares. - FY2017-Q3AchievedAnnual report
「The share acquisition rights issued during the three-month period ended in the third quarter are as follows.」
The issue of stock compensation-type share acquisition rights was completed during the third-quarter accounting period. The issue comprises 1,330 rights covering 133,000 shares. - FY2017-Q2First statedAnnual report
「The company will issue share acquisition rights to increase the alignment between the compensation of the company's directors, directors of its subsidiaries and executive officers, and the company's share price, and to further encourage their contribution to improving the company's performance and corporate value by sharing with shareholders not only the benefits of a rising share price but also the risks of a decline.」
The company resolved to issue stock compensation-type share acquisition rights linked to the share price for directors, subsidiary directors and executive officers. The issue comprises 1,330 rights allocated to 14 people.